Navigation Links
Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
Date:1/16/2012

MINNEAPOLIS, Jan. 16, 2012 /PRNewswire/ -- Zyga Technology, Inc. announced today that Jim Bullock has been named as the new President and CEO of the company.  Before joining Zyga Technology, Jim was President and CEO of Atritech, Inc. which was recently sold to Boston Scientific.  Prior to Atritech, Jim was President and CEO of Endocardial Solutions, Inc., which was acquired by St. Jude Medical. 

(Logo: http://photos.prnewswire.com/prnh/20110118/CG30384LOGO)

"I am extremely excited about the opportunities here at Zyga.  In today's environment, success is determined by products that are clinically validated to address the unmet needs of clinicians, and we are committed to meeting that challenge. We are excited about the traction we are gaining in the market with the SImmetry™ Sacroiliac Joint Fusion System, and the early clinical study results from the GLYDER™ Facet Resurfacing System. " said Jim Bullock

According to Dave Stassen, Chairman of the Board of Zyga Technology, Inc., and managing director of Split Rock Partners, "We are very pleased that Jim has joined the team at Zyga.  Jim has a phenomenal track record of creating value for start-up companies in the medical device industry.  Jim has been involved in medical devices throughout his career and brings a great deal of energy, commercialization success and strategic experience to Zyga."

Sacroiliac joint dysfunction and facetogenic pain have been shown to be the source of pain for up to 20% & 30% of patients suffering from low back pain respectively. Patients who suffer from these conditions typically receive therapeutic injections which temporarily address the problem but require long-term repeat treatments.  Traditional, open surgery has been performed to address these conditions but is limited in practice due to its complexity, high complication rate and generally poor outcomes.

About Zyga Technology, Inc.

Based in Minneapolis, MN, Zyga Technology, Inc. was founded to develop and market innovative, minimally invasive surgical solutions to treat conditions of the spine.  Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry.


'/>"/>
SOURCE Zyga Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
2. eResearchTechnology, Inc. to Present at the Thomas Weisel Healthcare Conference on September 4th, 2008
3. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
4. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
5. eResearchTechnology, Inc. to Announce 2008 Third Quarter Results on October 30, 2008
6. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
7. eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008
8. ERT (eResearchTechnology, Inc.) and Integrium, LLC Form Alliance to Deliver Integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring Services
9. Multisol France on Track to Sell 250 Tons of International Fuel Technology, Inc. Fuel Additive Formulations
10. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
11. Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
Breaking Biology News(10 mins):